Cherry Creek Investment Advisors, Inc. Pfizer Inc Transaction History

Cherry Creek Investment Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	SELL	$32.09 - $37.51 $14,504 - $16,954	-452 Reduced 1.44%	30,920 $1.03 Million
Q2 2023 Jul 14, 2023	BUY	$36.12 - $41.79 $14,881 - $17,217	412 Added 1.33%	31,372 $1.15 Million
Q1 2023 Apr 24, 2023	SELL	$39.39 - $51.28 $8,232 - $10,717	-209 Reduced 0.67%	30,960 $1.26 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $6,053 - $7,902	145 Added 0.47%	31,169 $1.6 Million
Q3 2022 Oct 24, 2022	BUY	$43.76 - $53.42 $11,640 - $14,209	266 Added 0.86%	31,024 $1.36 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $3,396 - $4,027	-73 Reduced 0.24%	30,758 $1.61 Million
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $13,496 - $16,723	-295 Reduced 0.95%	30,831 $1.6 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $26,775 - $39,690	648 Added 2.13%	31,126 $1.84 Million
Q3 2021 Nov 01, 2021	BUY	$39.25 - $50.42 $118,064 - $151,663	3,008 Added 10.95%	30,478 $1.31 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $986,447 - $1.12 Million	27,470 New	27,470 $1.08 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.